APA

Tanner J., Zhu A. Z., Claw K. G., Prasad B., Korchina V., Hu J., Doddapaneni H., Muzny D. M., Schuetz E. G., Lerman C., Thummel K. E., Scherer S. E. & Tyndale R. F. (20180713). Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. : Pharmacogenetics and genomics.

Chicago

Tanner Julie-Anne, Zhu Andy Z, Claw Katrina G, Prasad Bhagwat, Korchina Viktoriya, Hu Jianhong, Doddapaneni HarshaVardhan, Muzny Donna M, Schuetz Erin G, Lerman Caryn, Thummel Kenneth E, Scherer Steven E and Tyndale Rachel F. 20180713. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. : Pharmacogenetics and genomics.

Harvard

Tanner J., Zhu A. Z., Claw K. G., Prasad B., Korchina V., Hu J., Doddapaneni H., Muzny D. M., Schuetz E. G., Lerman C., Thummel K. E., Scherer S. E. and Tyndale R. F. (20180713). Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. : Pharmacogenetics and genomics.

MLA

Tanner Julie-Anne, Zhu Andy Z, Claw Katrina G, Prasad Bhagwat, Korchina Viktoriya, Hu Jianhong, Doddapaneni HarshaVardhan, Muzny Donna M, Schuetz Erin G, Lerman Caryn, Thummel Kenneth E, Scherer Steven E and Tyndale Rachel F. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. : Pharmacogenetics and genomics. 20180713.